Health and psychosocial status of patients with Turner syndrome after transition to adulthood: The Belgian experience

Hormone Research

Volumn 62, Issue 4, 2004, Pages 161-167

  Verlinde, F ^a   Massa, G ^a,i   Lagrou, K ^a   Froidecoeur, C ^a   Bourguignon, J P ^b   Craen, M ^c   De Schepper, J ^d   Du Caju, M ^e   Heinrichs, C ^f   Francois I ^g   Maes, M ^h  

^a Belg Stud Grp Paediatr E   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

ⁱ HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

Turner syndrome, health and psychosocial status; Turner syndrome, questionnaire; Turner syndrome, transition to adulthood

Indexed keywords

ESTROGEN; GROWTH HORMONE;

ADOLESCENT; ADULT; ADULTHOOD; ARTICLE; BODY MASS; CONTROLLED STUDY; EDUCATION; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH STATUS; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL CARE; MENSTRUATION; OCCUPATION; PRIORITY JOURNAL; PUBERTY; SOCIAL PSYCHOLOGY; TURNER SYNDROME;

ADOLESCENT; ADULT; AGING; DELIVERY OF HEALTH CARE; EDUCATION; EMPLOYMENT; FEMALE; HEALTH STATUS; HUMANS; MENTAL HEALTH; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; SOCIAL CLASS; TURNER SYNDROME;

EID: 7544233805     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080099     Document Type: Article

References (32)

1. Ranke M, Saenger P: Turner's syndrome. Lancet 2001;358:309-314.
2. Ostberg J, Conway G: Adulthood in women with Turner syndrome. Horm Res 2003;59:211-221.
3. Massa G, Heinrichs C, Verlinde S, Thomas M, Bourguignon JP, Craen M, François I, Du Caju M, Maes M, De Schepper J: Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. J Clin Endocrinol Metab 2003;88:4168-4174.
4. Elsheikh M, Dunger D, Conway G, Wass A: Turner's syndrome in adulthood. Endocr Rev 2002;23:120-140.
5. Sybert V: The adult patient with Turner syndrome; in Albertsson-Wikland K, Ranke M (eds): Turner Syndrome in a Life Span Perspective: Research and Clinical Aspects. Amsterdam, Elsevier, 1995, pp 205-218.
6. Nationaal instituut voor statistiek 2001: Bevolking en huishoudens. Totale Belgische bevolking op 1.1.2001, pp 112-113.
7. Nationaal instituut voor statistiek 2000: Enquête naar de arbeidskrachten. Totale Belgische bevolking, pp 26-27.
8. Callahan T, Winitzer F, Keenan P: Transition from pediatric to adult-oriented health care: A challenge for patients with chronic disease. Curr Opin Pediatr 2001;13:310-316.
9. Frias J, Davenport M: Health supervision for children with Turner syndrome. Pediatrics 2003;111:692-699.
10. Cunniff C, Hassed S, Hendon A, Rickert V: Health care utilisation and perceptions of health among adolescents and adults with Turner syndrome. Clin Genet 1995;48:17-22.
11. Poole R, Leatherdale B: An audit of adult women with Turner's syndrome: Is surveillance for comorbidity adequate? Clin Endocrinol 2002;56:561-562.
12. Landin-Wilhelmsen K, Sylvén L, Berntorp K, Karlsson A, Innala E, Ekman B, Bryman I, Wilhelmsen L: Swedish cardiac morbidity study in Turner syndrome; in Saenger P, Pasquino AM (eds): Optimizing Health Care for Turner Patients in the 21st Century. Amsterdam, Elsevier, 2000, pp 137-144.
13. Downey J, Ehrhardt A, Gruen R, Bell J, Morishima A: Psychopathology and social functioning in women with Turner syndrome. J Nerv Ment Dis 1989;177:191-201.
14. Gravholt C: Medical problems of adult Turner's syndrome. Horm Res 2001;56(suppl 1):44-50.
15. Sybert V: Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998;101:E11.
16. Elsheikh M, Casadei B, Conway G, Wass J: Hypertension is a major risk factor for aortic root dilatation in women with Turner's syndrome. Clin Endocrinol 2001;54:69-73.
17. Sylven L, Hagenfeldt K, Brondum-Nielsen K, von Schoultz B: Middle-aged women with Turner syndrome: Medical status, hormonal treatment and social life. Acta Endocrinol 1991;125:359-365.
18. Conway G, Elsheikh M, Cadge B, Ostberg J: Adult Turner follow-up - The Middlesex experience; in Saenger P, Pasquino AM (eds): Optimizing Health Care for Turner Patients in the 21st Century. Amsterdam, Elsevier, 2000, pp 295-306.
19. Gravholt C, Klausen I, Weeke J, Christiansen J: Lp(a) and lipids in adult Turner's syndrome: Impact of treatment with 17β-estradiol and norethisterone. Atherosclerosis 2000;150:201-208.
20. Snajderova M, Mardesic T, Lebl J, Gerzova H, Teslik L, Zapletalova J: The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose. Horm Res 2003;60:198-204.
21. Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L: Osteoporosis and fractures in Turner syndrome - Importance of growth-promoting and estrogen therapy. Clin Endocrinol 1999;51:497-502.
22. Gravholt C, Vestergaard P, Hermann A, Mosekilde L, Brixen K, Christiansen J: Increased fracture rates in Turner's syndrome: A nationwide questionnaire survey. Clin Endocrinol 2003;59:89-96.
23. Gravholt C, Naeraa R, Nyholm B, Gerdes L, Christiansen E, Schmitz O, Christiansen J: Glucose metabolism, lipid metabolism and cardiovascular risk factors in adult Turner's syndrome: Impact of sex hormone replacement. Diabetes Care 1998;21:1062-1070.
24. Elsheikh M, Bird R, Casadei B, Conway G, Wass A: The effect of hormone replacement therapy on cardiovascular hemodynamics in women with Turner's syndrome. J Clin Endocrinol Metab 2000;85:614-618.
25. Massa G, Bouillon R, Vanderschueren-Lodeweyckx M: Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol. J Clin Endocrinol Metab 1992;75:1298-1302.
26. Hankinson S, Willett W, Colditz G, Hunter D, Michaud D, Deroo B, Rosner B, Speizer F, Pollak M: Circulating concentrations of insulinlike growth factor-I and risk of breast cancer. Lancet 1998;351:1393-1396.
27. Toniolo P, Bruning P, Akhmedkhanov A, Bonfrer J, Koenig K, Lukanova A, Shore R, Zeleniuch-Jacquotte A: Serum insulin-like growth factor-I and breast cancer. Int J Cancer 2000;88:828-832.
28. Giovannucci E, Pollak N, Platz E, Willett W, Stampfer M, Majeed N, Colditz A, Speizer F, Hankinson S: A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000;9:345-349.
29. Beral V, Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
30. Rovet J: The psychoeducational characteristics of children with Turner syndrome. J Learn Disabil 1993;26:333-341.
31. Delooz J, Van den Berghe H, Swillen A, Kleczkowska A, Frijns JP: Turner syndrome patients as adults: A study of their cognitive profile, psychosocial functioning and psychopathological findings. Genet Couns 1993;3:169-179.
32. Pavlidis K, McCauley E, Sybert VP: Psychosocial and sexual functioning in women with Turner syndrome. Clin Genet 1995;47:85-89.